Category: General
Our 2023 Integrated Annual Report is live!
A year of innovation and impact In 2023, we entered the next phase of our journey of growth and innovation,
Q1 2024 sales update
Applications now open for the 2024 Golden Ticket competition
As part of our commitment to accelerating transformative research and development, we’re excited to announce that our annual Golden Ticket
FY 2023 results announcement
Ipsen sponsors 5 elite athletes on their journeys to the 2024 Paralympics
Starting now and throughout 2024, Ipsen is sponsoring five talented, elite athletes on their journeys toward the 2024 Paralympic Games.
Examining the European Pharma legislation: EFPIA publishes the Dolon Report
The European Federation of Pharmaceutical Industries and Associations (EFPIA) has commissioned Dolon to develop a report to assess the impact
Capital Markets Day 2023
Ipsen plans to host a capital-markets day, starting at 12.30 pm GMT on 7 December 2023, at The Brewery, London. In-person attendance is by invitation only. The event will be webcast live.
2023 year to date and third-quarter sales results
Ipsen has published its year to date and third-quarter sales results on 26 October 2023 at 7am CET. Press release
Winner of Ipsen’s golden ticket announced as newest resident of Biolabs Hôtel Dieu
We are pleased to announce that Hemerion has been awarded Ipsen’s golden ticket 2023, receiving a year’s free lab space at the